We are live on ! Find out more
David Shaw

David Shaw D.E. Shaw & Co

AUM $210B Turnover 26.1%
1-Year Est. Return 57.28%
 

David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.

This Fund
S&P 500
This Quarter Est. Return
+28.4%
1 Year Est. Return
+57.28%
3 Year Est. Return
+174.63%
5 Year Est. Return
+213.1%
10 Year Est. Return
+910%
AUM
$210B
AUM Growth
+$43.9B
Cap. Flow
+$8.31B
Cap. Flow %
3.95%
Top 10 Hldgs %
15.14%
Holding
5,360
New
872
Increased
1,718
Reduced
1,611
Closed
527
Avg Time Held Equity + Options
2.6 years
Top 10 Avg Time Held Equity + Options
0.4 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
2.6 years
Top 10 Avg Time Held Equity only
1.4 years
Top 20 Avg Time Held Equity only
1.3 years

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$2.17B
2
AVGO icon
Broadcom
AVGO
+$1.53B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
TSM icon
TSMC
TSM
+$928M
5
TXN icon
Texas Instruments
TXN
+$904M

Sector Composition

Rank Sector Weight
1 Miscellaneous 33.7%
2 Technology 18.77%
3 Financials 8.35%
4 Healthcare 7.91%
5 Consumer Discretionary 7.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RCKY icon
2851
Rocky Brands
RCKY
$387M
$2.63M ﹤0.01%
63,844
-26,953
-30% -$1.05M
2023 Q4
10 quarters
DMRC icon
2852
Digimarc Corp
DMRC
$174M
$2.63M ﹤0.01%
320,204
-11,205
-3% -$105K
2017 Q3
35 quarters
SMR icon
2853
PUT
NuScale Power
SMR
$2.08B
$2.63M ﹤0.01%
262,400
+48,700
+23% +$549K
2024 Q4
6 quarters
AMPY icon
2854
Amplify Energy
AMPY
$138M
$2.63M ﹤0.01%
660,670
+338,641
+105% +$1.74M
2025 Q3
3 quarters
IVW icon
2855
iShares S&P 500 Growth ETF
IVW
$72.1B
$2.63M ﹤0.01%
+19,116
New +$2.52M
2026 Q2
0 quarters
IP icon
2856
CALL
International Paper
IP
$18.3B
$2.63M ﹤0.01%
69,000
-41,300
-37% -$1.41M
2024 Q2
8 quarters
LCLN icon
2857
Lincoln International
LCLN
$905M
$2.63M ﹤0.01%
+110,000
New +$2.6M
2026 Q2
0 quarters
FLEX icon
2858
CALL
Flex
FLEX
$25.8B
$2.63M ﹤0.01%
16,200
– –
2025 Q3
3 quarters
AMBA icon
2859
CALL
Ambarella
AMBA
$2.58B
$2.63M ﹤0.01%
30,600
-800
-3% -$55.1K
2025 Q2
4 quarters
EPC icon
2860
Edgewell Personal Care
EPC
$1.29B
$2.62M ﹤0.01%
97,658
-44,739
-31% -$954K
2022 Q4
14 quarters
WGS icon
2861
CALL
GeneDx Holdings
WGS
$1.86B
$2.62M ﹤0.01%
38,200
+6,900
+22% +$392K
2024 Q4
6 quarters
CE icon
2862
PUT
Celanese
CE
$5.1B
$2.62M ﹤0.01%
57,000
-5,000
-8% -$289K
2025 Q3
3 quarters
LE icon
2863
Lands' End
LE
$276M
$2.61M ﹤0.01%
248,700
+184,111
+285% +$2.12M
2021 Q4
18 quarters
SLG icon
2864
PUT
SL Green Realty
SLG
$3.6B
$2.6M ﹤0.01%
50,300
– –
2024 Q3
7 quarters
GGAL icon
2865
CALL
Galicia Financial Group
GGAL
$4.73B
$2.6M ﹤0.01%
51,900
– –
2026 Q1
1 quarter
LGND icon
2866
CALL
Ligand Pharmaceuticals
LGND
$6.12B
$2.59M ﹤0.01%
8,200
+1,600
+24% +$377K
2025 Q3
3 quarters
TUYA icon
2867
Tuya Inc
TUYA
$987M
$2.58M ﹤0.01%
1,467,653
-592,272
-29% -$1.29M
2022 Q1
17 quarters
VICR icon
2868
CALL
Vicor
VICR
$6.78B
$2.58M ﹤0.01%
6,800
-5,600
-45% -$1.53M
2025 Q4
2 quarters
TRAX icon
2869
First Tracks Biotherapeutics
TRAX
$2.01B
$2.58M ﹤0.01%
+128,130
New +$2.4M
2026 Q2
0 quarters
UL icon
2870
CALL
Unilever
UL
$142B
$2.57M ﹤0.01%
42,800
-62,116
-59% -$3.59M
2025 Q3
3 quarters
FCEL icon
2871
CALL
FuelCell Energy
FCEL
$796M
$2.57M ﹤0.01%
+71,400
New +$1.16M
2026 Q2
0 quarters
IT icon
2872
PUT
Gartner
IT
$12B
$2.57M ﹤0.01%
19,800
+4,000
+25% +$602K
2025 Q3
3 quarters
PBYI icon
2873
Puma Biotechnology
PBYI
$426M
$2.57M ﹤0.01%
316,343
-34,892
-10% -$255K
2024 Q3
7 quarters
NPCE icon
2874
Neuropace
NPCE
$429M
$2.56M ﹤0.01%
161,081
+117,456
+269% +$1.89M
2026 Q1
1 quarter
MMI icon
2875
Marcus & Millichap
MMI
$1.05B
$2.56M ﹤0.01%
82,106
-82,279
-50% -$2.36M
2025 Q1
5 quarters

Similar funds

David Shaw's Q2 2026 Portfolio in Review

As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

David Shaw deployed $8.31B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 30% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.

  • David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
  • David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.6B increase.
  • David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
  • David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
  • David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
  • David Shaw opened 872 new positions and closed 527 in Q2 2026.
  • David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.